about
Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guidelineUse of inhaled and oral corticosteroids in pregnancy and the risk of malformations or miscarriageAnti-inflammatory pharmacotherapy during pregnancyAnti-inflammatory and immunosuppressive drugs and reproductionHuman pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing dataWomen, kidney disease, and pregnancyInflammatory bowel disease and pregnancy.Corticosteroid use during pregnancy and risk of orofacial cleftsMaternal, pregnancy and fetal outcomes in de novo anti-glomerular basement membrane antibody disease in pregnancy: a systematic review.Myasthenia gravis in pregnancy: a case report.A meta-analysis on the influence of inflammatory bowel disease on pregnancy.Drug therapy of inflammatory bowel disease in fertile women.Termination is not the treatment of choice for severe hyperemesis gravidarum: Successful management using prednisoloneThe use of antirheumatic disease drugs during pregnancy.Therapy of inflammatory bowel diseases in pregnancy and lactation.Anti-inflammatory glucocorticoid drugs: reflections after 60 years.The clinical management of hyperemesis gravidarum.Prenatal treatment of congenital adrenal hyperplasia-not standard of care.Prednisolone for repeated implantation failure associated with high natural killer cell levels.IBD medications during pregnancy and lactation.Glucocorticoids in myasthenia gravis - if, when, how, and how much?Therapeutic Review of Methylprednisolone Acetate Intra-Articular Injection in the Management of Osteoarthritis of the Knee - Part 2: Clinical and Procedural Considerations.Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines.Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.Maternal corticosteroid use and risk of selected congenital anomalies.Insulin-like growth factor II receptor, transforming growth factor-beta, and Cdk4 expression and the developmental epigenetics of mouse palate morphogenesis and dysmorphogenesis.Disease specific problems related to drug therapy in pregnancy.Developmental expression and CORT-regulation of TGF-beta and EGF receptor mRNA during mouse palatal morphogenesis: correlation between CORT-induced cleft palate and TGF-beta 2 mRNA expression.Long-term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.Corticosteroids during pregnancy and oral clefts: a case-control study.The potential role for corticosterone in the induction of cleft palate in mice after treatment with a selective NK-1 receptor antagonist, casopitant (GW679769B).
P2860
Q24614223-2E35A870-9F2C-4757-95D6-E8783FBA40D1Q26825323-1DED730B-37F6-4A98-9F68-901F2F46F680Q28167716-560A0D54-7FB7-4C44-BD8C-F7B46C12AFF9Q28218219-D7A7586A-E3B0-42C4-AB7E-7DDEE366B2ECQ31044246-BA2629A1-7774-4CE4-8CAD-B495071D16D3Q33410001-DFB16F2F-C209-4A0E-A28B-15433F186B75Q34268175-63088153-9760-4FFB-86AB-763DF7AD13E0Q34828505-2EFA43D9-1B54-4403-A626-42FC4BD616B3Q35232146-E83344F6-BAF9-4048-91DE-F1739AA87AD5Q35910426-9EA8DA7E-74A6-496C-95CE-8152AB111EDDQ35953861-42A6BE6B-16A0-4A51-8D7C-F278335B9A57Q36687466-3BF89A0F-9714-49B8-8D2F-6C4A75EB1B16Q37186464-C3F03ADD-7F1A-45F2-BAA5-1EF26B0C2E19Q37608422-8D686AF4-C092-45D4-9FEC-35AF72E76F49Q37615417-85C36044-DD2D-4FBF-BB40-0E35BFA0704EQ37808969-44D6F8EA-C092-46ED-A3F6-6C63EC70CEBDQ37855635-426D44B4-B0A7-4741-818B-EBFE9A040CEFQ38013728-50436188-6F51-45C7-BCA5-92FC91FF7DF1Q38025150-82313FF7-324E-4E07-8A68-679C504A85D2Q38125114-84A632B7-11F4-4EC6-81CC-E01C11B49089Q38234725-9D23C9C0-F492-4304-A67E-E671AAD79EF3Q38864251-1DFC66B2-8E98-4B64-9B9C-BA30927C2831Q39316691-9DFDEBA1-6EE0-4076-A293-AD6C571039D0Q39985558-BB465985-0756-4875-B34D-51D1167193CAQ41689861-0121CC9E-88B4-40A0-98B6-50E5C0340537Q44064597-8936CA70-8868-4FA5-9364-E041C62618F3Q45107051-A8C54793-C6FB-4CCD-A518-990B33E6803AQ45999746-57202009-F24E-4F28-90FB-217B701642CBQ46390308-BFEBBC79-8817-4213-BFF3-CF1BEF8FBF3BQ50871075-44911963-EF8E-4560-A9E2-0B183BDCDDE9Q51840084-18E4DFC4-7B34-4175-9283-5B2712AF0EFC
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Teratogenic potential of corticosteroids in humans.
@en
type
label
Teratogenic potential of corticosteroids in humans.
@en
prefLabel
Teratogenic potential of corticosteroids in humans.
@en
P356
P1476
Teratogenic potential of corticosteroids in humans.
@en
P2093
P356
10.1002/TERA.1420510107
P577
1995-01-01T00:00:00Z